HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 19 | 26 | 73.1% | |
| HF 4 | 2011 | 10 | 18 | 55.6% | |
| HF 4 | 2012 | 14 | 19 | 73.7% | |
| HF 4 | 2013 | 22 | 25 | 88.0% | |
| HF004(S) | 2014 | 0 | 0 | NA% | |
| HF004(S) | 2015 | 8 | 11 | 72.7% | |
| HF004(S) | 2016 | 6 | 6 | 100.0% |
